Mirati Therapeutics | MRTX - Umsatzerlöse



Der Umsatz Veränderung Datum
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amgen USD 9.9B 340M 2025-12
Astellas Pharma JPY 571.21B 46.89B 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
BioCryst Pharmaceuticals USD 406.56M 247.16M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Exelixis USD 598.66M 860K 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Incyte USD 1.51B 140M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
J&J USD 24.1B 500M 2026-03
Merck USD 16.4B 880M 2025-12
Moderna USD 678M 342M 2025-12
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novartis USD 13.86B 50M 2025-12
Pfizer USD 17.58B 880M 2025-12
Puma Biotechnology USD 80.54M 33.46M 2024-09
Roche Holding CHF 15.65B 274.5M 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Takeda JPY 1.19T 80B 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12